Загрузка...
Next Generation Chimeric Antigen Receptor T Cell Therapy: Going off the Shelf
Autologous, patient-specific chimeric antigen receptor T cell (CART) therapy has emerged as a powerful and potentially curative therapy for cancer, especially for CD19-positive hematological malignancies. Indeed, CD19-directed CART (CART-19) cell therapy (tisagenlecleucel-t) was Food and Drug Admini...
Сохранить в:
| Опубликовано в: : | BioDrugs |
|---|---|
| Главные авторы: | , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
2017
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5699508/ https://ncbi.nlm.nih.gov/pubmed/29143249 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40259-017-0247-0 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|